Article

Exploring the off-Label use of liraglutide in the treatment of obesity: a review

2025-05-13

Abstract excerpt

<title>Abstract</title> <p>Liraglutide, a glucagon-like peptide-1 (GLP-1) analog, has been used off-label for the treatment of obesity due to its considerable weight-reducing effects. This integrative review evaluated experimental studies in humans in order to explore the pharmacological mechanisms, metabolic effects, and the various clinical responses involved in the use of this drug. The research was conducted...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 01451200-690d-5e20-bfc4-33a3181309bf
DOI: 10.21203/rs.3.rs-6631957/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Exploring the off-Label use of liraglutide in the treatment of obesity: a reviewDOI 10.21203/rs.3.rs-6631957/v1Read

Clinical assessment of liraglutide use in prediabetic and obese schizophrenic patients: A systematic literature review and meta-analysisSemantic proximity Read

Evaluation of weight loss and metabolic changes in diabetic patients treated with liraglutide, effect of RS 6923761 gene variant of glucagon-like peptide 1 receptor.Semantic proximity Read

Obstetrician-Gynecologists' Strategies for Patient Initiation and Maintenance of Antiobesity Treatment with Glucagon-Like Peptide-1 Receptor AgonistsSemantic proximity Read

Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist.Semantic proximity Read

RISING STARS: Effects of a GLP-1 receptor polymorphism on responses to liraglutide.Semantic proximity Read

Highway to the danger zone? A cautionary account that GLP-1 receptor agonists may be too effective for unmonitored weight lossSemantic proximity Read

GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report.Semantic proximity Read

Clinically Effective Molecules of Natural Origin for Obesity Prevention or TreatmentSemantic proximity Read

The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options.Semantic proximity Read

Tirzepatide Synergizes with Leptin on Weight Loss and Restoring Metabolic Homeostasis in Diet-induced Obesity ModelSemantic proximity Read

Use of Liraglutide for obesity in HIV. A case reportSemantic proximity Read

Glucagon-Like Peptide-1 Receptor Agonists: A New Frontier in Treating Alcohol Use DisorderSemantic proximity Read